Showing results (181-190 of 205) with videos related to

Sort By:
Pageof 21
Human Molecular Genetics|January 7, 2021
Germline variants are associated with increased primary melanoma tumor thickness at diagnosisErnest Mangantig, Stuart MacGregor, Mark M Iles, et al.
Brain : a Journal of Neurology|May 10, 2018
JAK inhibitor improves type I interferon induced damage: proof of concept in dermatomyositisLeandro Ladislau, Xavier Suárez-Calvet, Ségolène Toquet, et al.
Science Advances|July 17, 2019
Control of TLR7-mediated type I IFN signaling in pDCs through CXCR4 engagement-A new target for lupus treatmentNikaïa Smith, Mathieu P Rodero, Nassima Bekaddour, et al.
Human Molecular Genetics|July 28, 2020
Multiplex melanoma families are enriched for polygenic riskMatthew H Law, Lauren G Aoude, David L Duffy, et al.
Rheumatology (Oxford, England)|May 15, 2025
Targeting interferon responses in juvenile dermatomyositis: Siglec-1 as an in vitro biomarker for JAK inhibitor efficacySaskia R Veldkamp, Maud Reugebrink, Sanne W Evers, et al.
Cytokine|May 4, 2021
Differential levels of IFNα subtypes in autoimmunity and viral infectionVincent Bondet, Mathieu P Rodero, Céline Posseme, et al.
The Journal of Allergy and Clinical Immunology|January 15, 2017
Disease-associated mutations identify a novel region in human STING necessary for the control of type I interferon signalingIsabelle Melki, Yoann Rose, Carolina Uggenti, et al.
The Journal of Allergy and Clinical Immunology|July 28, 2023
Pathogenic variants in the NLRP3 LRR domain at position 861 are responsible for a boost-dependent atypical CAPS phenotypeAntoine Fayand, Margaux Cescato, Laurent Le Corre, et al.
Pageof 21